Background: Pulmonary metastasectomy is considered a standard procedure in the treatment of metastatic colorectal cancer (CRC). Different prognostic factors including multiple metastatic nodules, the presence of extra-pulmonary metastases and BRAF mutation status have been associated with poor survival. The aim of this study was to evaluate which factors influenced survival in CRC patients undergoing pulmonary metastasectomy by studying primary tumors and pulmonary metastases.
Methods: All patients treated for primary CRC who presented pulmonary metastases in a 10-year period were considered (group A). A control group treated for primary CRC who did not develop any pulmonary or extra-pulmonary metastases was taken for comparison (group B). Different prognostic factors including gender, age, tumor location, histological type, inflammatory infiltrate, BRAF, CDX2 and extra-pulmonary metastases were analyzed. Overall survival (OS) and patients' survival after pulmonary metastasectomy were also considered.
Results: Fifty-four patients were evaluated in group A and twenty-three in group B. In group A, BRAF immunohistochemistry did not significantly differ between primary tumors and pulmonary metastases; no difference of BRAF expression was found between group A and B. Even the expression of CDX2 was not significantly different in primary tumors and metastases. Similarly, in group B CDX2 did not significantly differ from primary CRC of group A. The most significant prognostic factor was the presence of extra-pulmonary metastases. Patients with extra-pulmonary metastases experienced a significant shorter survival compared to patients with pulmonary metastases alone (P=0.001 with log-rank test P=0.003 with univariate Cox regression). Interestingly, patients with right pulmonary metastases presented a significant longer survival than those with left pulmonary metastases (P=0.027 with log-rank test 0.04 with univariate Cox regression).
Conclusions: The main prognostic factor associated with poor survival after lung resection of CRC metastases is a history of extra-pulmonary metastases. BRAF and CDX2 did not have a significant role in this small series of patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653500 | PMC |
| http://dx.doi.org/10.21037/jtd.2017.07.100 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Br J Cancer
November 2024
Adolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.
Article Synopsis
- - The Ewing Sarcoma Family of Tumors (ESFT) includes rare cancers, with a significant portion showing metastatic spread, especially affecting bone and bone marrow, which worsens prognosis and necessitates stronger treatments.
- - The French phase II COMBINAIR3 study compared the effectiveness of PET/CT to traditional bone marrow aspiration and biopsy (BMAB) for staging extra-pulmonary metastatic ESFT in 42 patients.
- - Results indicated that PET/CT had high specificity (100%) and notable sensitivity (83.3%) in detecting bone marrow involvement, suggesting it can replace BMAB for initial staging, thereby enhancing treatment planning for high-risk ESFT patients.
Cardiac Metastasis from Myxoid Liposarcoma Managed Successfully with Chemotherapy and Radiotherapy: Case Report and Review of the Literature.
Curr Oncol
September 2024
Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Article Synopsis
- Liposarcoma is a common type of sarcoma known for spreading to areas outside the lungs, including rare cases of heart metastases, often requiring surgical intervention for treatment.
- A 62-year-old man with a myxoid liposarcoma developed a metastasis in his heart 19 years after his initial surgery, which was treated successfully with chemotherapy and radiotherapy instead of surgery.
- This case highlights the importance of using non-surgical treatment methods for managing cardiac metastases from sarcomas, showing that effective long-term outcomes can be achieved without surgery, contradicting the belief that surgery is always necessary for such cases.
Primary Tumor Resection in Leiomyosarcoma Patients With Synchronous Isolated Lung Metastases: A National Cancer Database Study.
J Surg Res
August 2024
Division of Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:
Article Synopsis
- Leiomyosarcoma (LMS) often presents with isolated lung metastases, but there is limited evidence on how to manage these cases effectively.
- A study analyzed data from 629 LMS patients with synchronous isolated lung metastases, revealing that those treated at academic centers had better surgical outcomes.
- The findings suggest that aggressive surgical approaches, including resection of both primary tumors and lung metastases, can significantly improve overall survival rates, particularly for patients treated in specialized high-volume centers.
Unmasking the Common Thief: A Rare Cause of Isolated Hypoglossal Nerve Palsy.
J Community Hosp Intern Med Perspect
November 2023
Cure Drug Repurposing Collaboratory, United States.
Multiple cranial nerve palsies frequently accompany hypoglossal nerve palsy, potentially indicating malignancy, such as lymphoma, nasopharyngeal carcinoma, or metastases. However, when solely the hypoglossal nerve is affected, the causes may involve Chiari malformation, arachnoid cyst, or infectious mononucleosis, suggesting a positive prognosis. Craniocervical junction tuberculosis (TB), is an uncommon cause of isolated hypoglossal nerve palsy and has been reported infrequently in the literature.
View Article and Find Full Text PDFNeuroendocrine Carcinoma of the Hypopharynx - An Elusive Clinical Rarity.
Indian J Otolaryngol Head Neck Surg
February 2024
Department of Otorhinolaryngology, JIPMER, Puducherry, 06 India.
Neuroendocrine carcinoma originating from neuroendocrine cells is typically linked to unfavourable survival rates. We are introducing an exceptional case of neuroendocrine carcinoma occurring in the hypopharynx. To date, only a handful of instances involving primary neuroendocrine carcinoma of the hypopharynx have been documented.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!